Trials / Completed
CompletedNCT04706494
A Study to Investigate the Efficacy of AlphaWave® L-Theanine on Stress
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Investigate the Efficacy of an Acute Dose of AlphaWave® LTheanine on Stress in a Healthy Adult Population
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Ethical Naturals, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
AlphaWave® L-theanine will be compared against placebo to evaluate how the investigational study product effects on salivary cortisol, EEG readings, blood pressure, and heart rate in a moderately stressed and otherwise healthy adult population. It is hypothesized that participants taking the AlphaWave® L-theanine will have reduced stress levels as assessed by the parameters stated. Participants will be consuming the investigational study product or placebo in the clinic only.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AlphaWave® LTheanine | 200 mg of AlphaWave® LTheanine |
| DIETARY_SUPPLEMENT | Placebo | microcrystalline cellulose |
Timeline
- Start date
- 2020-02-02
- Primary completion
- 2020-09-25
- Completion
- 2020-09-25
- First posted
- 2021-01-12
- Last updated
- 2021-01-12
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04706494. Inclusion in this directory is not an endorsement.